St Jude CE marks "less invasive" neurostimulation lead delivery system
This article was originally published in Clinica
Executive Summary
St Jude Medical has CE marked its Epiducer lead delivery system, used to implant neurostimulation devices, for sale in Europe. Neurostimulation therapy is used to manage chronic pain, and involves implantation of a paddle lead in the epidural space near the spine. Mild electrical impulses are delivered from a neurostimulator to the leads' electrodes, to interrupt or mask pain signals to the brain. The new system allows physicians to implant paddle leads through a single percutaneous entry point – previously, this had to be done via laminotomy, a more invasive surgical procedure in which part of the spine typically has to be removed. St Jude (St Paul, Minnesota) markets several neurostimulation systems, including Genesis and Eon Mini.